Guided graded exercise self-help for chronic fatigue syndrome: Long term follow up and cost-effectiveness following the GETSET trial.
Clark, Lucy V, McCrone, Paul, Pesola, Francesca et al. · Journal of psychosomatic research · 2021 · DOI
Quick Summary
This study followed up with CFS patients one year after they received either guided graded exercise self-help (a structured program to gradually increase activity) or standard medical care. While the exercise program showed better results after 12 weeks, by 15 months both groups had improved similarly, with the exercise group maintaining their gains and the standard care group catching up. The exercise program cost slightly more but was considered cost-effective based on quality of life improvements.
Why It Matters
This study provides important evidence on the durability of graded exercise interventions beyond the short-term and demonstrates cost-effectiveness data relevant to healthcare policy decisions about CFS treatment options. Understanding long-term trajectories of both intervention and standard care helps patients and clinicians make informed decisions about treatment approaches.
Observed Findings
Short-term fatigue improvements in the GES group were maintained at 15-month follow-up.
The SMC-alone group showed delayed improvement, with fatigue reduction occurring between 12 and 15 months.
At 15-month follow-up, no significant differences remained between GES and SMC groups on either fatigue or physical functioning.
GES incurred £85 higher healthcare costs but generated additional quality-adjusted life years.
The incremental cost-effectiveness ratio of £4,802 per QALY was below the standard NHS threshold of £20,000-£30,000 per QALY.
Inferred Conclusions
Short-term benefits of guided graded exercise self-help are durable over longer follow-up periods.
Both intervention and standard medical care produce improvements in CFS symptoms, though on different timelines.
Guided graded exercise self-help may represent a cost-effective use of healthcare resources compared to specialist medical care alone.
The convergence of outcomes suggests that factors beyond the intervention itself contribute to long-term CFS outcomes.
Remaining Questions
Why does the SMC group show delayed improvement between 12 and 15 months, and what mechanisms drive this recovery?
What This Study Does Not Prove
This study does not prove that graded exercise is the best treatment for all CFS patients, as both groups improved over time and differences disappeared at follow-up. It also cannot establish whether the improvements were due to the exercise program itself, natural recovery, regression to the mean, or other unmeasured factors. The cost-effectiveness conclusion carries substantial uncertainty and may not apply to all healthcare contexts.
Do certain patient characteristics predict who benefits most from early versus delayed intervention approaches?
How do these findings apply to CFS patients in primary care versus secondary care settings, and to international healthcare systems with different cost structures?
What proportion of improvement is attributable to the guided self-help intervention itself versus natural recovery, expectation effects, or concurrent lifestyle changes?